Clinical Trial

Evaluating the Feasibility, Acceptability, and Initial Clinical Effectiveness of Implementing a Cognitive Remediation Program Within Psychiatric Services.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Severe and persistent mental health disorders are associated with impairments in cognitive, emotional, and social functioning. Some of these disorders involve cognitive challenges that are likely to negatively affect quality of life. In this context, the early identification of cognitive difficulties and intervention through cognitive remediation become priority therapeutic targets to facilitate individual rehabilitation. From this perspective, the present study aims to determine the relevance of a personalized cognitive remediation program developed by neuropsychologists at Pierre-Janet Hospital, called RECAMEX, to guide its sustainable adoption and to support its implementation in other clinical settings.
Trial Details
NCT Number NCT07446140
Lead Sponsor The Royal Ottawa Mental Health Centre
Conditions Severe and Persistent Mental Illness
Enrollment 87 participants
Start Date 2026-03-01
Primary Completion 2029-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-03